Quotient offers comprehensive biomarker services
A
Quotient BioResearch product story
Edited by the Laboratorytalk editorial team
Oct 5, 2009
Quotient Research has announced that it is supporting a key industry trend with comprehensive biomarker services for drug development.
The company said it offers expertise in marker development, the establishment and validation of methods, and routine quantification of almost 250 different biomarkers.
Biomarkers can be correlated with biological events to validate drug targets or to predict drug response.
In addition, they may be used to characterise and stratify patient populations, helping researchers understand the extent to which a new drug reaches its intended therapeutic target.
Importantly, data from clinically validated biomarkers is becoming increasingly required by regulators as they make decisions regarding drug approval.
Not what you're looking for? Search the site.
Google Ads
Contact Quotient BioResearch
Related Stories
- Biotech cluster creates partnership opportunities
- Evotec offers Hypha products to screening clients
- GRI services thermal cyclers at reduced price
- Event to highlight Northern Ireland's oncology hub
- Microscience gains Microscopy Society support
Browse by category
- Analytical instruments (9827)
- Life sciences and clinical laboratory equipment (4021)
- Computer hardware (854)
- Industry news (20)
- Laboratory equipment and wares (6566)
- Laboratory supplies and consumables (1395)
- Pumps, Valves, Filters (760)
- Services (3292)
- Contract research (974)
- Laboratory and scientific exhibitions and conferences (270)
- Laboratory and scientific recruitment (28)
- Laboratory and scientific consultancy services (333)
- Laboratory and scientific training and education (437)
- Laboratory building and design (59)
- Laboratory and scientific manufacturing services (148)
- Laboratory and scientific professional organisations (560)
- Laboratory and scientific books and publishing (482)
- Computer software (3080)
